Global Intravenous Solutions Market Report 2023: Players Include ICU Medical, JW Life Science, Otsuka Pharmaceutical and Pfizer - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intravenous Solutions Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031" report has been added to ResearchAndMarkets.com's offering.

The global intravenous solutions market is expected to grow at 8.0% by 2031.

Companies Mentioned

• Amanta Healthcare Ltd.
• Axa Parenterals Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Eurolife Healthcare Pvt Ltd.
• Fresenius Kabi AG
• Grifols S.A
• Henry Schein Inc.
• ICU Medical Inc.
• JW Life Science
• Otsuka Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Salius Pharma Private Limited
• Sichuan Kelun Pharmaceutical Co. Ltd
• Soxa Formulations & Research (Pvt.) Ltd.
• Vifor Pharma Management Ltd

Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in the Asia-Pacific region.

Intravenous products are highly regulated for quality and availability assurance. Though matured, this market has been undergoing continuous evolution, thus experiencing steady growth.

The intravenous solutions manufacturers and vendors worldwide are perpetually improving the nature of products, and sales and distribution methods respectively. Several large players have employed direct sales force and independent distributors, retail and wholesalers.

Alternate modes of supply are also employed by the manufacturers to retain profitability. Third parties that store and deliver products for the manufacturer have a significant foothold in developed markets. These type of vendors are found to better cater swift customer service as they always stock adequate inventories.

Other sales practices in this market include sales through customer and sales service representatives, catalogue circulation and merchandising, electronic purchase facility and allied benefits, e-mail campaign, publicity through trade publications and trade fairs and others.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

Market Segmentation

Type

• Partial Parenteral Nutrition
• Age Group
• Pediatric
• Adult
• Total Parenteral Nutrition
• Age Group
• Pediatric
• Adult

Composition

• Carbohydrates
• Vitamins and Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others

End Users

• Hospitals and Clinics
• Ambulatory Surgery Centers
• Home care settings

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Intravenous Solutions market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2031.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Intravenous Solutions market?
• Which is the largest regional market for Intravenous Solutions market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Intravenous Solutions market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Intravenous Solutions market worldwide?

For more information about this report visit https://www.researchandmarkets.com/r/kvqedk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900